Author(s):
Vikram S. Gharge, Krishna B. Kinage, Anup A. Kulkarni, Rohit S. Kharade
Email(s):
vikram.gharge@zuventus.com
DOI:
10.52711/2231-5659.2025.00001 
Address:
Vikram S. Gharge, Krishna B. Kinage, Anup A. Kulkarni, Rohit S. Kharade
1Zuventus Healthcare Limited Plot No. P-2, SBM, Ground Floor (Part-b) and First Floor. I.T.B.T. Park, Phase –II, Midc Hinjawadi, Pune – 411057.
*Corresponding Author
Published In:
Volume - 15,
Issue - 1,
Year - 2025
ABSTRACT:
The present article describes formulation and evaluation of Mefenamic acid suspension. Mefenamic acid is BCS class II drugs i.e. low solubility and high permeability. Mefenamic acid suspension was formulated for pediatric patient. Major challenge is to mask a bitter taste of Mefenamic acid. The taste masking of Mefenamic acid is achieved by the matrix-based technology in drug adsorbed or entrapped in the matrix of the porous component. This may result in a delayed release of the bitter active during the transit through the oral cavity. Mefenamic acid suspensions were formulated using different concentration of Xanthan gum, Carbopol 934 P and Veegum K. The Sucrose and artificial sweetener were added to mask a bitter taste. The trials of Mefenamic acid suspension were evaluated for different parameters like macroscopy, pH, viscosity, taste evaluation, In-vitro drug release and assay. Based on the result, F 6 batch was selected for further study. The F 6 batch gives optimum viscosity, No sedimentation and phase separation. The percentage of drug release was found 100.99% at 60 minutes. The F6 formulation is sweet in taste with pleasant odour. So, based on the physical and chemical parameter of taste masked F6 formulation of mefenamic acid gives promising career for pediatric delivery.
Cite this article:
Vikram S. Gharge, Krishna B. Kinage, Anup A. Kulkarni, Rohit S. Kharade. Advancements in Pharmaceutical Formulations: Formulation and Evaluation of Taste-Masked Suspension of Mefenamic Acid. Asian Journal of Research in Pharmaceutical Sciences. 2025; 15(1):1-6. doi: 10.52711/2231-5659.2025.00001
Cite(Electronic):
Vikram S. Gharge, Krishna B. Kinage, Anup A. Kulkarni, Rohit S. Kharade. Advancements in Pharmaceutical Formulations: Formulation and Evaluation of Taste-Masked Suspension of Mefenamic Acid. Asian Journal of Research in Pharmaceutical Sciences. 2025; 15(1):1-6. doi: 10.52711/2231-5659.2025.00001 Available on: https://ajpsonline.com/AbstractView.aspx?PID=2025-15-1-1
REFERENCES:
1. Kishan Pal Singh, Santosh Dighe. Taste Masking of Bitter Drugs in Pharmaceutical Suspension: A Review. Asian Journal of Pharmacy and Technology. 2023; 13(4):270-4.
2. A.K. Gupta; A. Kumar; M. Dalal. Practical Approaches For Taste Masking of Bitter Drug: A Review. International Journal of Drug Delivery Technology. 2010; 2(2): 56-61
3. M.K. Sikandar; P.K. Sharma; R. Malviya. Taste Masking: an important Pharmaceutical Technology for the Improvement of Organoleptic Property of pharmaceutical Active Agents. European Journal of Biological Sciences. 2011; 3(3): 67-71
4. S. Sharma; S. Lewis. Taste Masking Technologies: A Review. International Journal of Pharmacy and Pharmaceutical Sciences. 2010; 2(2): 6-13
5. D. Sharma; D. Kumar. Taste masking Technologies: A Novel Approach for The Improvement of Organoleptic Proprety of Pharmaceutical Active Substance. International Research Journal of Pharmacy. 2012; 3(4): 108-116
6. M. Suthar; M. M. Patel. Formulation and evaluation of taste masked suspension of metronidazole. International Journal of Applied Pharmaceutics. 2011; 3(1): 16-19.
7. Amaravathi Vikram, S. Firoz. Enhancement solubility and dissolution of mefenamic acid by modified starch. International Journal of Pharmaceutical Development and Technology. 2012; 2(2): 85-92.
8. Sachin N. Kothawade, Ashwini Ishware, Priyanka Darekar, Amit S. Lunkad. Formulation and Evaluation of Sustained Release Matrix Tablet of Mefenamic Acid. Res. J. Pharm. Dosage Form. and Tech. 2014; 6(4): 249-252.
9. Gehan H. Hegazy, Hamed I. Ali, Design, synthesis, biological evaluation, and comparative cox1 and Cox 2 Docking of p-substituted benzylidenamino phenyl esters of ibuprofenic and mefenamic acids. Bioorganic and Medicinal Chemistry. 2012; 20: 1259–1270
10. Vaibhav Changediya, Rupalben Jani, Pradip Kakde. Development and Evaluation of Mefenamic acid Nanoemulsion. Research J. Pharm. and Tech. 2021; 14(2): 1003-1007.
11. Rachit Khullar; Deepinder Kumar. Formulation and evaluation of mefenamic acid emulgel for topical delivery. King Saud University, Saudi Pharmaceutical Journal. 2012; 20: 63-67
12. Serap Cesur; Cihan Yaylaci. Process and Technology, Optimum Kinetic Parameters of Mefenamic Acid Crystallization by PBM. Journal of Crystallization. 2012; 2: 81-95
13. Arpita Tupe, S.D. Mankar. Nanosuspension: A Novel Approach to Improve the Solubility, Bioavailability and Pharmacokinetics of Poorly Soluble Drugs. Asian Journal of Pharmacy and Technology. 2023; 13(3): 194-0.
14. M. H. Markad, S. D. Mankar. Review on: Solubility Enhancement of Poorly Water-Soluble Drugs. Asian Journal of Research in Pharmaceutical Sciences. 2022; 12(3): 231-8.
15. Dipali Patil, Shashikant Barhate, Manoj Bari, Shaikh Samir. Formulation and Evaluation of Extended Release Oral Suspension of Metformin Hydrochloride. Research Journal of Pharmaceutical Dosage Forms and Technology. 2024; 16(1): 6-2.
16. AM Avachat, SB Bhise. Development and Characterization of a Stable Suspension of Rifampicin and Isoniazid. Research J. Pharma. Dosage Forms and Tech. 2009; 1(3): 213-216
17. H.Sohi; R.K. Khar; Y.Sultana. Taste Masking Technologies in Oral Pharmaceuticals: Recent Developments and approaches. Drug Development and Industrial Pharmacy. 2004; 30(5): 429–448
18. Bhoyar PK, Biyani DM, Shahare HV, Ikhar PK, Borkar VS. Formulation and Evaluation of Taste Masked Sustained Release Dosage Form of Metformin Hydrochloride Using Indion Resin. Research J. Pharma. Dosage Forms and Tech. 2009; 1(1): 49-54.
19. Swati Paul, Dibyajyoti Saha. Comparative Studies on Sedimentation Parameter of Aluminium Hydroxide and Sodium Bicarbonate, Magnesium Trisilicate, Magnesium Carbonate Suspension. Asian J. Pharm. Tech. 2012; 2(4): 133-134.
20. Sayad Basha.K, Sheema Nafees. S, Nethravani. G, Thirumalesh Naik S.B. Formulation and Evaluation of Diclofenac Suspension by Using Natural Suspending Agents. Res. J. Pharm. Dosage Form. and Tech. 2016; 8(2): 119-121.
21. Smita S. Aher, Sagar T. Malsane, R. B. Saudagar. Nanosuspension: An Overview. Asian J. Res. Pharm. Sci. 2017; 7(2):81-86
22. Pawar Pravin, Yadav Adhikrao, Gharge Varsha. Different Techniques for Preparation of Nanosuspension with Reference to its Characterisation and various Applications - A Review. Asian J. Res. Pharm. Sci. 2018; 8(4): 210-216.
23. Vidya Ashok Kheradkar, Jameel Ahmed S. Mulla. Nanosuspension: A Novel Technology for Drug Delivery. Asian Journal of Research in Pharmaceutical Sciences. 2023; 13(2): 106-0.